GSK sells thrombosis drugs to Aspen for $1 billion

LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline agreed the 700 million pounds ($1.13 billion) sale of its thrombosis drug brands and a related factory to Aspen Pharmacare , as part of its strategy to focus on growth products. The company said on Monday the divestment to South Africa's biggest generic drug maker would earn it proceeds of 600 million pounds and 100 million pounds of the headline price related to inventory. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/aspen-agrees-buy-gsk-drugs-967-million-112238910--finance.html